ArticleThe Journal of infectious diseases2024

Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants.

Robert A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.